ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2025

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease-mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1-3 chronic kidney disease.

Daniel Hsiang-Te Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.